Johnson Matthey Plc
Overview
Johnson Matthey Plc is a multinational specialty chemicals and sustainable technologies company focused on clean air, clean energy, and low-carbon technologies. The company operates in multiple sectors, providing advanced materials and sustainable technology solutions.
API / Drug Master Files
Johnson Matthey Plc holds 0 active (18 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- D-AMPHETAMINE ADIPATEInactive2002-04-26
- RAC-AMPHETAMINE ADIPATEInactive2002-04-26
- METAXALONEInactive2001-08-30
- AMD 3100Inactive1998-05-26
- MEPERIDINE HCI, USPInactive1998-04-09
- LANTHANUM CARBONATEInactive1997-11-05
- NAPHAZOLINE HYDROCHLORIDEInactive1994-09-02
- GOLD SODIUM THIOMALATEInactive1993-05-07
- AUROTHIOGLUCOSEInactive1993-05-05
- PROCHLORPERAZINE EDISYLATEInactive1993-04-22
- BAHNH (CYTOGEN LINKER)Inactive1992-08-08
- CNS-1044Inactive1992-06-12
- AURANOFINInactive1992-04-30
- ORMAPLATINInactive1992-01-27
- DMP LACTATEInactive1991-03-28
Showing 15 of 18 Drug Master Files.
FDA compliance signals
5 FDA enforcement records linked to this company.
- recall — Class II2019-10-02
cGMP Deviations: Potential glass contamination
- recall — Class II2019-10-02
cGMP Deviations: Potential glass contamination
- recall — Class II2019-10-02
cGMP Deviations: Potential glass contamination
- recall — Class III2019-04-24
Failed Impurities/Degradation Specifications: Unknown impurity above specification limits.
- recall — Class II2019-04-10
Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.